<DOC>
	<DOCNO>NCT00170430</DOCNO>
	<brief_summary>The purpose study see take medication month help decrease risk vaginal infection . Additionally , researcher study whether personal habit , douche , bathing , sexual practice influence risk vaginal infection . Vaginal infection may influence risk become infect HIV-1 sexually transmit disease ( STDs ) . Study participant include 400 female prostitute age 16 older , live Mombasa . Study procedure include sexual behavior question , physical examination include pelvic exam , test vaginal cervical secretion STDs , urine collection blood sample . Participants receive 2 different type pill treat vaginal infection ( metronidazole fluconazole ) placebo ( contain medication ) . Participants involve study related procedure 1 year return study clinic one month interval .</brief_summary>
	<brief_title>Reducing Vaginal Infections Women</brief_title>
	<detailed_description>Prospective study Africa demonstrate vaginal infection associate significant increase woman 's risk infection HIV-1 . Further clinical epidemiological research need evaluate strategy prevention treatment vaginal infection mean reduce HIV-1 acquisition . Developing vaginal health intervention reduce risk HIV-1 infection particularly important goal sub-Saharan Africa , female control strategy reduce risk HIV-1 transmission may important mean decrease spread epidemic . This study evaluate efficacy regimen reduce rate vaginal infection . The study double blind , randomize , control trial monthly treatment single-dose metronidazole fluconazole mean decrease vaginal infection promote normal vaginal flora HIV-1 seronegative female sex worker ( FSWs ) Mombasa , Kenya . Participants recruit exist cohort HIV-1 seronegative FSWs follow municipal sexually transmitted disease ( STD ) clinic Mombassa , Kenya , since February 1993 . Participants randomize treatment metronidazole 2 gram plus fluconazole 150 mg month placebo . All patient ask return follow-up 1 month . All woman study treat indicated symptomatic vaginal infection , genital track infection follow complete 12 monthly follow-up visit .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Sexually Transmitted Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Women currently symptoms vaginal itching discharge . Women symptom may treat enrolled subsequent monthly visit asymptomatic . Those currently menstruate may enrol completion menses . Pregnancy Lactation History adverse reaction study medication Alcoholism inability abstain alcohol 48 hour follow treatment Women anticipate living Mombasa year follow enrollment .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>HIV-1 , sexually transmit disease , female , Kenya</keyword>
</DOC>